| P50 | author | Sean G Young | Q59691505 |
| P2093 | author name string | Andrew Kitchen | |
| | Margaret Carrel | |
| | Ghazi Kayali | |
| P2860 | cites work | Avian influenza A(H5N1) in humans: lessons from Egypt | Q39000442 |
| | Avian influenza H5N1 virus infections in vaccinated commercial and backyard poultry in Egypt. | Q39040909 |
| | Global occurrence and spread of highly pathogenic avian influenza virus of the subtype H5N1. | Q39177425 |
| | Surveillance of avian influenza viruses in migratory birds in Egypt, 2003-09. | Q39476418 |
| | The Use of Spatial and Spatiotemporal Modeling for Surveillance of H5N1 Highly Pathogenic Avian Influenza in Poultry in the Middle East | Q39679322 |
| | Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets | Q39709717 |
| | Analysis of a point mutation in H5N1 avian influenza virus hemagglutinin in relation to virus entry into live mammalian cells | Q39914238 |
| | Amantadine-resistance among H5N1 avian influenza viruses isolated in Northern China | Q40075929 |
| | PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice | Q40579478 |
| | The spread process of epidemic influenza in the continental United States, 1968-2008. | Q42225060 |
| | The H5N1 moratorium controversy and debate | Q42391667 |
| | A Comprehensive Surveillance of Adamantane Resistance among Human Influenza a Virus Isolated from Mainland China between 1956 and 2009 | Q42909963 |
| | Two amino acid residues in the matrix protein M1 contribute to the virulence difference of H5N1 avian influenza viruses in mice | Q43175209 |
| | Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice | Q43176186 |
| | Surveillance activities and molecular analysis of H5N1 highly pathogenic avian influenza viruses from Thailand, 2004-2005. | Q43176288 |
| | Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. | Q43177474 |
| | Biologic potential of amantadine-resistant influenza A virus in an avian model | Q43714146 |
| | Single mutation at the amino acid position 627 of PB2 that leads to increased virulence of an H5N1 avian influenza virus during adaptation in mice can be compensated by multiple mutations at other sites of PB2. | Q45385093 |
| | Virulence of H5N1 avian influenza virus enhanced by a 15-nucleotide deletion in the viral nonstructural gene | Q45396717 |
| | Recent H5N1 avian influenza A virus increases rapidly in virulence to mice after a single passage in mice | Q45410215 |
| | Emerging pathogens: the epidemiology and evolution of species jumps | Q56783570 |
| | Notes on Continuous Stochastic Phenomena | Q56913292 |
| | Use of spatial epidemiology and hot spot analysis to target women eligible for prenatal women, infants, and children services | Q64110737 |
| | A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence | Q21089626 |
| | Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro | Q21142648 |
| | GenBank | Q22065976 |
| | The influenza virus enigma | Q24616614 |
| | Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity | Q24646829 |
| | Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets | Q27314689 |
| | Cross-Species Virus Transmission and the Emergence of New Epidemic Diseases | Q27486915 |
| | Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma | Q28235537 |
| | Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia | Q28265766 |
| | Evolution of the receptor binding phenotype of influenza A (H5) viruses | Q28277115 |
| | Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam | Q28473743 |
| | Large-scale spatial population databases in infectious disease research | Q28730483 |
| | Ducks: the "Trojan horses" of H5N1 influenza | Q28751332 |
| | A comparison of spatial clustering and cluster detection techniques for childhood leukemia incidence in Ohio, 1996-2003 | Q28762916 |
| | Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses | Q29619144 |
| | Airborne transmission of influenza A/H5N1 virus between ferrets | Q29619970 |
| | Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets | Q29619972 |
| | Influenza A H5N1 immigration is filtered out at some international borders | Q30010997 |
| | Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors | Q30230269 |
| | Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir | Q30306773 |
| | Influenza type A in humans, mammals and birds: determinants of virus virulence, host-range and interspecies transmission. | Q30333000 |
| | Avian flu: isolation of drug-resistant H5N1 virus. | Q30351638 |
| | The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. | Q30352150 |
| | Host range restriction and pathogenicity in the context of influenza pandemic. | Q30354432 |
| | Phylogeography of influenza A H5N1 clade 2.2.1.1 in Egypt. | Q30356659 |
| | An avian influenza H5N1 virus that binds to a human-type receptor. | Q30362874 |
| | Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. | Q30364619 |
| | Selection of H5N1 influenza virus PB2 during replication in humans | Q37192151 |
| | A single-amino-acid substitution in a polymerase protein of an H5N1 influenza virus is associated with systemic infection and impaired T-cell activation in mice | Q37410786 |
| | A practical guide to environmental association analysis in landscape genomics. | Q38548998 |
| | Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt | Q38981457 |
| | Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. | Q30365053 |
| | Human infection with highly pathogenic H5N1 influenza virus. | Q30369081 |
| | Positive selection at the receptor-binding site of haemagglutinin H5 in viral sequences derived from human tissues. | Q30370726 |
| | Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza. | Q30373409 |
| | Characterization of H5N1 influenza virus variants with hemagglutinin mutations isolated from patients | Q30373481 |
| | Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. | Q30374182 |
| | Zanamivir-resistant influenza viruses with a novel neuraminidase mutation | Q30379353 |
| | Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic. | Q30383545 |
| | Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host | Q30383968 |
| | In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity | Q30388086 |
| | Risk assessment of recent Egyptian H5N1 influenza viruses | Q30396067 |
| | Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors | Q30397253 |
| | An overview of the epidemic of highly pathogenic H5N1 avian influenza virus in Egypt: epidemiology and control challenges. | Q30399136 |
| | Neuraminidase inhibitor sensitivity and receptor-binding specificity of Cambodian clade 1 highly pathogenic H5N1 influenza virus | Q30400058 |
| | Acquisition of human-type receptor binding specificity by new H5N1 influenza virus sublineages during their emergence in birds in Egypt. | Q30403405 |
| | Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species | Q30406151 |
| | In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. | Q30409010 |
| | Adjuvant solution for pandemic influenza vaccine production | Q30422038 |
| | Novel phylogenetic algorithm to monitor human tropism in Egyptian H5N1-HPAIV reveals evolution toward efficient human-to-human transmission | Q30430279 |
| | A research agenda: does geocoding positional error matter in health GIS studies? | Q30485425 |
| | Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. | Q33243576 |
| | Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. | Q33263979 |
| | Genomic analysis and geographic visualization of the spread of avian influenza (H5N1). | Q33283007 |
| | The influenza virus resource at the National Center for Biotechnology Information | Q33303008 |
| | The special neuraminidase stalk-motif responsible for increased virulence and pathogenesis of H5N1 influenza A virus | Q33483360 |
| | The HA and NS Genes of Human H5N1 Influenza A Virus Contribute to High Virulence in Ferrets | Q33700611 |
| | Combining spatial-temporal and phylogenetic analysis approaches for improved understanding on global H5N1 transmission | Q33735972 |
| | Molecular characterization of avian influenza H5N1 virus in Egypt and the emergence of a novel endemic subclade. | Q33761804 |
| | Global spatiotemporal and genetic footprint of the H5N1 avian influenza virus | Q33764162 |
| | Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations | Q33804210 |
| | Role of host-specific amino acids in the pathogenicity of avian H5N1 influenza viruses in mice | Q33885412 |
| | A mutation in H5 haemagglutinin that conferred human receptor recognition is not maintained stably during duck passage | Q33898593 |
| | Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry | Q33934663 |
| | Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model | Q33987340 |
| | A molecular and antigenic survey of H5N1 highly pathogenic avian influenza virus isolates from smallholder duck farms in Central Java, Indonesia during 2007-2008. | Q34012407 |
| | Permissive secondary mutations enable the evolution of influenza oseltamivir resistance | Q34118992 |
| | Lethal H5N1 influenza viruses escape host anti-viral cytokine responses | Q34146021 |
| | Population distribution, settlement patterns and accessibility across Africa in 2010. | Q34171312 |
| | Egyptian H5N1 influenza viruses-cause for concern? | Q34481825 |
| | A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo | Q34485350 |
| | The epidemiological and molecular aspects of influenza H5N1 viruses at the human-animal interface in Egypt | Q34703972 |
| | Avian influenza H5N1 viral and bird migration networks in Asia | Q34926617 |
| | Cluster of human infections with avian influenza A (H7N9) cases: a temporal and spatial analysis | Q35015190 |
| | Effect of an asparagine-to-serine mutation at position 294 in neuraminidase on the pathogenicity of highly pathogenic H5N1 influenza A virus | Q35076785 |
| | The virulence of 1997 H5N1 influenza viruses in the mouse model is increased by correcting a defect in their NS1 proteins | Q35077820 |
| | Host- and strain-specific regulation of influenza virus polymerase activity by interacting cellular proteins | Q35169989 |
| | Reversion of PB2-627E to -627K during replication of an H5N1 Clade 2.2 virus in mammalian hosts depends on the origin of the nucleoprotein | Q35275017 |
| | Enhancing phylogeography by improving geographical information from GenBank | Q35417455 |
| | Combining phylogeography and spatial epidemiology to uncover predictors of H5N1 influenza A virus diffusion | Q35431133 |
| | Avian influenza A(H5N1) and A(H9N2) seroprevalence and risk factors for infection among Egyptians: a prospective, controlled seroepidemiological study | Q35715601 |
| | Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus | Q35758840 |
| | Continuing threat of influenza (H5N1) virus circulation in Egypt. | Q35848998 |
| | Zoonotic transmission of avian influenza virus (H5N1), Egypt, 2006-2009. | Q35877072 |
| | Increased Number of Human Cases of Influenza Virus A(H5N1) Infection, Egypt, 2014-15. | Q36353903 |
| | A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice | Q36424206 |
| | Isolation of avian influenza H5N1 virus from vaccinated commercial layer flock in Egypt. | Q36539014 |
| | Sequence and phylogenetic analysis of highly pathogenic avian influenza H5N1 viruses isolated during 2006-2008 outbreaks in Pakistan reveals genetic diversity | Q36539100 |
| | Microevolution of highly pathogenic avian influenza A(H5N1) viruses isolated from humans, Egypt, 2007-2011. | Q36584392 |
| | Avian Influenza A(H5N1) Virus in Egypt | Q36617093 |
| | A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. | Q36685680 |
| | A single amino acid at the hemagglutinin cleavage site contributes to the pathogenicity but not the transmission of Egyptian highly pathogenic H5N1 influenza virus in chickens. | Q36760101 |
| | Geographical epidemiology, spatial analysis and geographical information systems: a multidisciplinary glossary | Q36768838 |
| | The threat of avian influenza A (H5N1). Part III: Antiviral therapy. | Q36790658 |
| | Changes in H5N1 influenza virus hemagglutinin receptor binding domain affect systemic spread. | Q37068350 |
| | Influenza a virus polymerase is an integral component of the CPSF30-NS1A protein complex in infected cells | Q37099780 |
| | PB2 protein of a highly pathogenic avian influenza virus strain A/chicken/Yamaguchi/7/2004 (H5N1) determines its replication potential in pigs | Q37099830 |
| | Neuraminidase stalk length and additional glycosylation of the hemagglutinin influence the virulence of influenza H5N1 viruses for mice | Q37157266 |
| P433 | issue | 1 | |
| P921 | main subject | avian influenza | Q43987 |
| | pandemic potential | Q45881698 |
| | spatial pattern | Q105047828 |
| P304 | page(s) | 314 | |
| P577 | publication date | 2018-07-06 | |
| P1433 | published in | BMC Infectious Diseases | Q15759919 |
| P1476 | title | Unlocking pandemic potential: prevalence and spatial patterns of key substitutions in avian influenza H5N1 in Egyptian isolates. | |
| P478 | volume | 18 | |